Ken Griffin’s Orphazyme A/S ORPH Stock Holding History

Ken Griffin’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-95,007	Closed	-$229K	–	15182
2021 Q4	$229K	Buy	+95,007	New	+$335K	﹤0.01%	11580
2021 Q3	–	Sell	-107,220	Closed	-$552K	–	15165
2021 Q2	$788K	Buy	+107,220	New	+$864K	﹤0.01%	8985
2020 Q4	–	Sell	-200,000	Closed	-$2.07M	–	11763
2020 Q3	$2.07M	Buy	+200,000	New	+$2M	﹤0.01%	4649

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Ken Griffin's ORPH Position: Q1 2022 in Review

Ken Griffin sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 95,007 shares — an estimated $229K sold.

Ken Griffin first reported a position in ORPH in Q3 2020 and held it in 3 quarters. The position peaked at $2.07M in Q3 2020. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

Ken Griffin reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
Ken Griffin sold 95,007 Orphazyme A/S shares in Q1 2022, an estimated $229K.
Ken Griffin first reported a position in Orphazyme A/S in Q3 2020 and held it in 3 quarters.
Ken Griffin's Orphazyme A/S position peaked at $2.07M in Q3 2020.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.